Bavarian Nordic: A Success Story in the Face of Buyout Offers
In the heart of the corporate landscape, Bavarian Nordic has emerged as a shining example of resilience and strategic foresight, particularly in light of the decisions made by ATP and private investors to reject the buyout offers from private equity firms Nordic Capital and Permira in the autumn of 2025. Now, as we navigate through the autumn of 2026, the financial data substantiates this decision with clear indications of the company's robust performance.
At the time of the buyout offer, the private equity firms initially proposed a price of 233 DKK per share, later increasing it to 250 DKK. However, as of now, Bavarian Nordic shares are trading steadily around 247 DKK, demonstrating solid fundamental growth and stability within the company.
Key Insights from the Rejecting the Buyout Offer
Several critical conclusions can be drawn from this unfolding narrative:
1. Long-Term Potential Outweighed the Buyout Firms' "Discount". Private equity firms often target companies during periods of temporary setbacks to acquire them at lower prices, streamline operations away from public scrutiny, and eventually sell them at a premium. Investors, including ATP and Michael Voss, who collectively own 35% of the company's equity, recognized that the 250 DKK price was a "hasty price" that did not reflect Bavarian Nordic's true potential.
As evidence of this potential, Bavarian Nordic revised its expectations for the third time in 2026, driven by strong demand for vaccines, including rabies and travel vaccines. The company's revenue is now projected to reach approximately 6.1 billion DKK with an EBITDA margin around 32%.
2. Institutional Patience Pays Off. Pension funds like ATP operate on a different timeline compared to private equity firms. With ownership exceeding 10% of the company, ATP clearly expressed its desire to be a "long-term owner". By rejecting the buyout offer, ATP ensured that the future value creation and significant vaccine orders remained with existing shareholders rather than being privatized by foreign funds. Furthermore, the company launched its own share buyback program in 2026, signaling that it generates sufficient liquidity to return capital to loyal shareholders.
3. Market Sees Even Greater Future Value. Although the current stock price hovers closely to the maximum buyout offer of 250 DKK, the story does not end here. Analysts indicate more potential upside, with the average price target among financial institutions currently sitting at 276.25 DKK. The company has also embarked on a new chapter with the appointment of Tarja Stenvall as the new CEO, a move that has been positively received by the market and ATP alike.
In summary, the investors' decision to resist the lure of a quick profit in 2025 has secured the current growth trajectory, strong upgrades, and future upside for existing shareholders rather than allowing it to fall into the hands of a private equity firm.
As reported by proinvestor.com.
